Discover Ocugen's Q1 2025 earnings insights, focusing on gene therapy advancements, key clinical trials, and financial updates.

Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.

Companies are already moving to hike their prices as U.S. tariffs bite, a move economists say is likely to drive up inflation ...

Madi Beumee told Newsweek that, while she will still "sob" at her friends' weddings, other milestones are important, too.

Federal health officials want to collect individuals' health data so they can answer questions about autism and chronic ...

TIM's management has missed its guidance targets countless times in recent years, so we remain cautious. On top of a more than EUR 4 billion cash cushion after the divestment of its fixed network, TIM ...